Topic: Miscellaneous

SEC Significantly Expands Confidential Review of Registration Statements
SEC Eliminates Need for Affirmative “Tandy” Representations from Issuers
NASDAQ Proposes Disclosure of Third-Party Compensation for Directors and Nominees
When the Tail Wags the Unicorn: SEC Chair Voices Concerns About Pre-IPO Investments
SEC Files Fraud Charges Against Public Biotechnology Company and its Officers for Alleged Materially Misleading FDA-Related Disclosures
“FAST” Act Legislation Enacted -- Potentially Significant Impact on Capital Markets
NASDAQ Issues FAQ Relaxing Historical Position on Net Share Settled Convertible Securities
House Financial Services Committee Approves Eight Bills Affecting Securities Regulation
Corp Fin Issues Revised Statement on WKSI Waivers
Corp Fin Updates Compliance and Disclosure Interpretations
1 - 10 Next

© Copyright 2017 Gibson, Dunn & Crutcher LLP.
Attorney Advertising. Prior results do not guarantee a similar outcome. All information provided on this site is for informational purposes only, does not constitute legal advice, is not confidential, and does not create an attorney-client relationship. Statements and content posted to this site do not represent the opinion of Gibson Dunn & Crutcher LLP ("Gibson Dunn"). Gibson Dunn makes no representations as to the accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors or omissions therein, nor for any losses, injuries, or damages arising from its display or use.